DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Zydus Wellness Limited — Updates

NSE 24 Aug·24 Aug 2026, 4:22 pm

Zydus Wellness

Zydus Wellness Limited has informed stock exchanges that it has made a disclosure under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This regulatory filing is a standard procedural update required when a listed company has material information to share with the market.

For investors, this disclosure does not necessarily indicate any negative news or a specific event. It is a routine step to ensure transparency and compliance with market regulations. The company is obligated to notify the exchange whenever it becomes aware of information that could influence the trading price of its shares.

Investors should monitor the official exchange filings for the specific details of this disclosure. Until the company provides further clarification, the stock's price is likely to remain stable. It is advisable to wait for the official press release to understand the context behind this regulatory filing.